Zoom's stock has dropped significantly from its pandemic peak, but the company has shown improvements in net margins and maintains a strong cash balance. The introduction of AI tools like AI Companion 2.0 and Workvivo, with applications in healthcare, education, and frontline markets, further supports its growth potential. These factors suggest that the stock is undervalued and may see positive movement ahead of its Q4 earnings.